NAPOLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.276
EU - Europa 1.776
AS - Asia 449
OC - Oceania 21
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.529
Nazione #
US - Stati Uniti d'America 2.269
PL - Polonia 630
RU - Federazione Russa 586
IE - Irlanda 171
SE - Svezia 135
HK - Hong Kong 131
SG - Singapore 114
CN - Cina 105
IT - Italia 97
DE - Germania 47
JO - Giordania 44
FI - Finlandia 31
IN - India 23
GB - Regno Unito 22
AU - Australia 21
CH - Svizzera 14
BE - Belgio 13
VN - Vietnam 13
ES - Italia 11
ID - Indonesia 9
AT - Austria 7
CA - Canada 7
TR - Turchia 7
CI - Costa d'Avorio 5
UA - Ucraina 4
NL - Olanda 3
DK - Danimarca 2
EG - Egitto 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
NO - Norvegia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 4.529
Città #
Santa Clara 761
Warsaw 628
Chandler 176
Dublin 171
Fairfield 163
Ashburn 125
Cambridge 95
Singapore 94
Hong Kong 86
Ann Arbor 83
Seattle 82
Houston 78
Woodbridge 72
Wilmington 59
Beijing 41
Princeton 35
Altamura 34
Bremen 31
Lawrence 31
Buffalo 29
Florence 29
Shanghai 27
Boston 21
Melbourne 21
Boardman 20
Kent 19
Medford 17
Mumbai 17
San Diego 17
New York 15
Bern 14
Brussels 12
Barcelona 11
Council Bluffs 11
Helsinki 9
Jakarta 8
Falls Church 7
Jacksonville 7
Moscow 7
Vienna 7
Dong Ket 6
Phoenix 6
West Jordan 6
Abidjan 5
Norwalk 5
Pune 5
Toronto 5
London 4
Los Angeles 4
Redmond 4
Guangzhou 3
Hillsboro 3
Izmir 3
Lappeenranta 3
Latina 3
Washington 3
Bologna 2
Copenhagen 2
Frankfurt am Main 2
Munich 2
Philadelphia 2
Radomsko 2
Sesto Fiorentino 2
Shenzhen 2
Surrey 2
Andover 1
Aprilia 1
Arezzo 1
Atlanta 1
Bangkok 1
Baotou 1
Central District 1
Falkenstein 1
Harbin 1
Hounslow 1
Kafr ash Shaykh 1
Kilburn 1
Kunming 1
Laurel 1
Lisbon 1
Lucca 1
Miami 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Newark 1
Oggiono 1
Paceco 1
Palermo 1
Redwood City 1
Rui'an 1
Seoul 1
Taiyuan 1
Tappahannock 1
Udine 1
Valdobbiadene 1
Wenzhou 1
Yubileyny 1
Zhengzhou 1
Totale 3.290
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 290
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 257
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 246
Druggable Targets in Pancreatic Adenocarcinoma 240
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 197
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 187
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 146
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 141
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 141
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 128
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 121
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 121
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 116
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 112
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 106
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 106
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 100
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 97
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 96
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 95
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 95
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 94
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 91
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 87
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 82
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 82
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 81
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 81
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 79
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 76
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 73
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 71
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results 71
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 70
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 68
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 64
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 63
Molecular analysis of the FHIT gene in human sporadic colon cancers. 59
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 54
Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS) 54
The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC) 51
Totale 4.589
Categoria #
all - tutte 12.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020319 0 0 0 0 0 0 72 72 60 46 61 8
2020/2021364 34 40 1 49 19 31 34 21 38 45 29 23
2021/2022242 6 22 11 13 7 16 6 26 15 12 39 69
2022/2023818 59 128 40 80 63 140 105 49 104 3 18 29
2023/2024335 7 26 43 10 18 48 30 88 6 15 33 11
2024/20251.696 68 189 132 365 592 340 10 0 0 0 0 0
Totale 4.589